TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Trastuzumab Deruxtecan in Anti-Human Epidermal Growth Factor Receptor 2 Treatment-Naive Patients With Human Epidermal Growth Factor Receptor 2-Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial.

Kensei Yamaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.